NetScientific is a transatlantic healthcare IP commercialisation group.
Our Portfolio
Targeting chronic diseases
OUR TEAM
Sector-specialist senior management team with extensive commercial experience.
Sir Richard Sykes, FRS
Sir Richard Sykes, Non-Executive Chairman of the Group, joined NetScientific in 2008. Sir Richard spent thirty years working in the biotechnology and pharmaceutical industries, …
ChairmanIan Postlethwaite
Ian Postlethwaite, Chief Executive Office, Chief Financial Officer & Company Secretary, joined NetScientific in June 2016. He brings over 14 years of biopharma experience …
Chief Executive Officer, Chief Financial Officer & Company Secretary
NEWS
NetScientific plc (“NetScientific” or the “Company”) Appointment to the Board London, UK – 14 October 2019 – NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, …
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company PDS Biotechnology collaborates with Merck in Phase 2 studies for PDS0101 in metastatic head and neck cancer and high-risk …
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company PDS Biotechnology to prioritise lead immunotherapy treatment in high-risk human papillomavirus (HPV) into Phase 2 studies London, UK – …
NetScientific plc
PO Box 76075
London
EC3P 3DX
Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net
copyright
NetScientific healthcare technology group